SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Shionogi links edaravone to longer ALS progression-free survival

Shionogi reports an association between edaravone and longer progression-free survival in a real-world data analysis.

Related stories